Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis

首页 > 成果 > 详情

认领

导出

下载 Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Wang, Ying;Kuang, Ze-Min;Feng, Shu-Jun;Jiang, Long;Chen, Qiu-Xian;...

通讯作者：

Hu, Hong-Juan

作者机构：

[Wang, Ying; Feng, Shu-Jun] Univ South China, Peoples Hosp Chenzhou 1, Dept Cardiol, Chenzhou, Hunan, Peoples R China.

[Kuang, Ze-Min; Cheng, Wen-Li] Capital Med Univ, Beijing Anzhen Hosp, Dept Hypertens, Beijing, Peoples R China.

[Jiang, Long] Nanchang Univ, Affiliated Hosp 2, Inst Cardiovasc Dis, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.

[Ji, Xiao-Yun; Chen, Qiu-Xian] Hisun Pfizer Pharmaceut Co Ltd, Dept Med Affairs, Shanghai, Peoples R China.

[Hu, Hong-Juan] Univ South China, Sch Nursing, Teaching & Res Sect Community Nursing, Hengyang, Hunan, Peoples R China.

通讯机构：

[Hu, Hong-Juan] U

Univ South China, Sch Nursing, Teaching & Res Sect Community Nursing, Hengyang, Hunan, Peoples R China.

语种：

英文

关键词：

*cardiovascular events;*hypertension;*prevention;*protocol;*statin;*systematic review

期刊：

BMJ OPEN

ISSN：

2044-6055

年：

2018

卷：

期：

页码：

e019719

DOI：

10.1136/bmjopen-2017-019719

基金类别：

Funding This study is supported by the Basic and Clinical Research Cooperation Project of Capital Medical University (No. 16JL42); the Presidential Foundation of Beijing Anzhen Hospital Affiliated with Capital Medical University (No. 2016P01); Scientific Research Fund of Hunan Provincial Education Department (No. 16c1396); Hunan Provincial Innovation Foundation For Postgraduate (Primary Study on the Function of New Gene of ARMC5 in Patients with Primary Bilateral Macronodular Adrenal Hyperplasia, No. CX2016B493).

机构署名：

本校为第一且通讯机构

院系归属：

护理学院

摘要：

Introduction High blood pressure (BP) affects over 40% of adults over the age of 25 worldwide and is the leading global risk factor for death or disability. Hypertension is also the most important risk factor for endovascular atherosclerosis, which, when combined with other cardiovascular risk factors, leads to atherosclerotic cardiovascular disease (ASCVD). Statins are one of the most widely used drugs for the prevention of ASCVD. The recently announced study of Heart Outcomes Prevention Evaluation-3 suggests that cholesterol-lowering agents c...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问